E. Ardite et al., EFFECTS OF STEROID TREATMENT ON ACTIVATION OF NUCLEAR FACTOR KAPPA-B IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE, British Journal of Pharmacology, 124(3), 1998, pp. 431-433
Nuclear factor kappa B (NF kappa B) is a transcription factor that con
trols several genes important for immunity and inflammation. The aim o
f this study was to assess if activation of NF kappa B plays a role in
the pathogenesis of inflammatory bowel disease (IBD), and whether ste
roid treatment affects NF kappa B activation. Activation of NF kappa B
was analysed in colon biopsy samples of 13 patients with active IBD (
8 Crohn's colitis, 5 ulcerative colitis) by electrophoretic mobility-s
hift assays, under basal conditions and 3 weeks after treatment with 0
.75 mg kg(-1) day(-1) prednisolone. The presence of interleukin-8 mRNA
in biopsies was assessed by RT-PCR. A specific NF kappa B band was pr
esent in all nuclear extracts from inflamed mucosa, whereas the band w
as barely detectable in uninflamed colonic mucosa. NF kappa B bands we
re super-shifted by antibodies against p50 subunit, whereas antibodies
against p65, p52, c-Rel, or Rel B did not modify the mobility of the
band. Increased interleukin-8 mRNA was detected at the same sites of N
F kappa B activation. Steroid-induced healing of colonic inflammation
was associated with disappearance of NF kappa B from nuclear extracts.
These results support the notion that NF kappa B plays an important r
ole in the pathogenesis of IBD, and that blockade of NF kappa B activa
tion is one of the mechanisms by which steroids suppress the inflammat
ory cascade in IBD.